Vertex Extends Portfolio Pricing and Reimbursement Approach To Denmark

Vertex has succeeded in bringing its portfolio-based approach to the pricing and reimbursement of its cystic fibrosis treatments to another market, Denmark. This follows similar deals in Ireland and Sweden.